These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31538930)

  • 21. Pneumococcal haemolytic uraemic syndrome in the postvaccine era.
    Lawrence J; Gwee A; Quinlan C
    Arch Dis Child; 2018 Oct; 103(10):957-961. PubMed ID: 29674516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
    von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
    Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?
    Debbache K; Varon E; Hicheri Y; Legrand P; Donay JL; Ribaud P; Cordonnier C
    Clin Microbiol Infect; 2009 Sep; 15(9):865-8. PubMed ID: 19549222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Makwana A; Sheppard C; Borrow R; Fry N; Andrews NJ; Ladhani SN
    Pediatr Infect Dis J; 2018 Jul; 37(7):697-703. PubMed ID: 29889811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran.
    Houri H; Tabatabaei SR; Saee Y; Fallah F; Rahbar M; Karimi A
    Int J Infect Dis; 2017 Apr; 57():21-26. PubMed ID: 28131730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR; Adam HJ; Zhanel GG;
    Vaccine; 2016 May; 34(23):2527-30. PubMed ID: 27085174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.
    Lepoutre A; Varon E; Georges S; Gutmann L; Lévy-Bruhl D
    Euro Surveill; 2008 Aug; 13(35):. PubMed ID: 18761883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.
    Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Shane A; Zhanel GG; Tyrrell GJ; Gilmour MW; ;
    Can J Microbiol; 2012 Aug; 58(8):1008-17. PubMed ID: 22827750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Law PY; Chiu SS
    Hum Vaccin Immunother; 2019; 15(2):455-458. PubMed ID: 30261157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
    Demczuk WHB; Martin I; Desai S; Griffith A; Caron-Poulin L; Lefebvre B; McGeer A; Tyrrell GJ; Zhanel GG; Gubbay J; Hoang L; Levett PN; Van Caeseele P; Raafat Gad R; Haldane D; Zahariadis G; German G; Daley Bernier J; Strudwick L; Mulvey MR
    Vaccine; 2018 Jul; 36(31):4701-4707. PubMed ID: 29937245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
    Allemann A; Frey PM; Brugger SD; Hilty M
    Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
    Kovács E; Sahin-Tóth J; Tóthpál A; Kristóf K; van der Linden M; Tirczka T; Dobay O
    Vaccine; 2019 Jan; 37(1):99-108. PubMed ID: 30470639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
    Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
    Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
    PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.
    Leal J; Vanderkooi OG; Church DL; Macdonald J; Tyrrell GJ; Kellner JD
    Pediatr Infect Dis J; 2012 Sep; 31(9):e169-75. PubMed ID: 22673137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.